Cargando…
First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative
[Figure: see text]
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618780/ https://www.ncbi.nlm.nih.gov/pubmed/35939788 http://dx.doi.org/10.1182/bloodadvances.2022007977 |
| _version_ | 1784821129567797248 |
|---|---|
| author | Azuma, Hiroshi Amano, Toraji Kamiyama, Naoya Takehara, Naofumi Jingu, Maki Takagi, Harumi Sugita, Osamu Kobayashi, Naoko Kure, Tomoko Shimizu, Taro Ishida, Tatsuhiro Matsumoto, Masanori Sakai, Hiromi |
| author_facet | Azuma, Hiroshi Amano, Toraji Kamiyama, Naoya Takehara, Naofumi Jingu, Maki Takagi, Harumi Sugita, Osamu Kobayashi, Naoko Kure, Tomoko Shimizu, Taro Ishida, Tatsuhiro Matsumoto, Masanori Sakai, Hiromi |
| author_sort | Azuma, Hiroshi |
| collection | PubMed |
| description | [Figure: see text] |
| format | Online Article Text |
| id | pubmed-9618780 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96187802022-11-01 First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative Azuma, Hiroshi Amano, Toraji Kamiyama, Naoya Takehara, Naofumi Jingu, Maki Takagi, Harumi Sugita, Osamu Kobayashi, Naoko Kure, Tomoko Shimizu, Taro Ishida, Tatsuhiro Matsumoto, Masanori Sakai, Hiromi Blood Adv Research Letter [Figure: see text] The American Society of Hematology 2022-08-10 /pmc/articles/PMC9618780/ /pubmed/35939788 http://dx.doi.org/10.1182/bloodadvances.2022007977 Text en © 2022 by The American Society of Hematology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Research Letter Azuma, Hiroshi Amano, Toraji Kamiyama, Naoya Takehara, Naofumi Jingu, Maki Takagi, Harumi Sugita, Osamu Kobayashi, Naoko Kure, Tomoko Shimizu, Taro Ishida, Tatsuhiro Matsumoto, Masanori Sakai, Hiromi First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative |
| title | First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative |
| title_full | First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative |
| title_fullStr | First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative |
| title_full_unstemmed | First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative |
| title_short | First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative |
| title_sort | first-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618780/ https://www.ncbi.nlm.nih.gov/pubmed/35939788 http://dx.doi.org/10.1182/bloodadvances.2022007977 |
| work_keys_str_mv | AT azumahiroshi firstinhumanphase1trialofhemoglobinvesiclesasartificialredbloodcellsdevelopedforuseasatransfusionalternative AT amanotoraji firstinhumanphase1trialofhemoglobinvesiclesasartificialredbloodcellsdevelopedforuseasatransfusionalternative AT kamiyamanaoya firstinhumanphase1trialofhemoglobinvesiclesasartificialredbloodcellsdevelopedforuseasatransfusionalternative AT takeharanaofumi firstinhumanphase1trialofhemoglobinvesiclesasartificialredbloodcellsdevelopedforuseasatransfusionalternative AT jingumaki firstinhumanphase1trialofhemoglobinvesiclesasartificialredbloodcellsdevelopedforuseasatransfusionalternative AT takagiharumi firstinhumanphase1trialofhemoglobinvesiclesasartificialredbloodcellsdevelopedforuseasatransfusionalternative AT sugitaosamu firstinhumanphase1trialofhemoglobinvesiclesasartificialredbloodcellsdevelopedforuseasatransfusionalternative AT kobayashinaoko firstinhumanphase1trialofhemoglobinvesiclesasartificialredbloodcellsdevelopedforuseasatransfusionalternative AT kuretomoko firstinhumanphase1trialofhemoglobinvesiclesasartificialredbloodcellsdevelopedforuseasatransfusionalternative AT shimizutaro firstinhumanphase1trialofhemoglobinvesiclesasartificialredbloodcellsdevelopedforuseasatransfusionalternative AT ishidatatsuhiro firstinhumanphase1trialofhemoglobinvesiclesasartificialredbloodcellsdevelopedforuseasatransfusionalternative AT matsumotomasanori firstinhumanphase1trialofhemoglobinvesiclesasartificialredbloodcellsdevelopedforuseasatransfusionalternative AT sakaihiromi firstinhumanphase1trialofhemoglobinvesiclesasartificialredbloodcellsdevelopedforuseasatransfusionalternative |